ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 19 filers reported holding ARRAY BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $162,000 | +32.8% | 90,000 | 0.0% | 0.10% | +13.5% |
| Q2 2017 | $122,000 | -4.7% | 90,000 | 0.0% | 0.09% | -12.7% |
| Q1 2017 | $128,000 | +1.6% | 90,000 | 0.0% | 0.10% | -15.7% |
| Q4 2016 | $126,000 | +18.9% | 90,000 | 0.0% | 0.12% | +24.7% |
| Q3 2016 | $106,000 | +39.5% | 90,000 | 0.0% | 0.10% | +31.1% |
| Q2 2016 | $76,000 | +5.6% | 90,000 | 0.0% | 0.07% | +1.4% |
| Q1 2016 | $72,000 | -13.3% | 90,000 | 0.0% | 0.07% | +2.8% |
| Q4 2015 | $83,000 | -6.7% | 90,000 | 0.0% | 0.07% | -9.0% |
| Q3 2015 | $89,000 | – | 90,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,000,000 | $53,278,000 | 2.48% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,000,000 | $6,018,000 | 0.85% |
| CSS LLC/IL | 10,546,000 | $12,816,000 | 0.62% |
| Verition Fund Management LLC | 3,400,000 | $4,025,000 | 0.43% |
| Redmile Group, LLC | 4,000,000 | $4,761,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,600,000 | $23,231,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,139,000 | $13,378,000 | 0.20% |
| LINDEN ADVISORS LP | 2,000,000 | $2,374,000 | 0.11% |
| Fernwood Investment Management, LLC | 90,000 | $106,000 | 0.10% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,000,000 | $5,909,000,000 | 0.09% |